Clinical Trials Logo

Filter by:
NCT ID: NCT05165238 Completed - Multiple Sclerosis Clinical Trials

Impact Program for Multiple Sclerosis

Start date: January 10, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the effects of a four week diet coaching program on pain, fatigue, mood, and dietary habits among adults with multiple sclerosis.

NCT ID: NCT05165173 Completed - Clinical trials for Kidney Failure, Chronic

Almond Milk With Vitamin D: Impact on Vitamin D Status

Start date: May 22, 2023
Phase: N/A
Study type: Interventional

The overall goal is to enhance vitamin D status in a safe and effective manner. A 3-week randomized comparator-controlled trial among a cohort of adults with CKD (stages 3-5) (n=24) will test the main objective: Evaluate the bioefficacy of D3 in micro- and nanoparticles (4000IUs) in almond milk with the sub-objective of: Explore the effect of D3 in micro- and nanoparticles (4000IUs) in almond milk on inflammation markers CRP, TNF-α and IL-6.

NCT ID: NCT05165121 Completed - Hearing Loss Clinical Trials

Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

Hearing aids are commonly used to help people with hearing loss hear better in daily listening environments. MDHearing Smart hearing aids are designed to use the MDHearing app to adjust hearing aids to each individual's hearing loss. This study intends to show whether the MDHearing Smart hearing aids can be fitted by each user reliably and if each user can use the MDHearing app on their smartphone or tablet to make adjustments to achieve good aided benefit, which will be compared to those fitted by audiology professionals. This study includes three components: human factor study, self-fit study, and professional-fit study. The information obtained will be useful for both audiology professionals and people with impaired hearing.

NCT ID: NCT05164133 Completed - COVID-19 Clinical Trials

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19

Start date: June 10, 2022
Phase: Phase 1
Study type: Interventional

This is a single-arm, open-label study to assess the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of tocilizumab (TCZ) for the treatment of pediatric patients from birth to less than 18 years old hospitalized with COVID-19 and who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.

NCT ID: NCT05164120 Completed - COVID-19 Clinical Trials

Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19

Start date: December 14, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to assess the safety, tolerability and treatment effect of the orally administered Caspase-1 inhibitor, belnacasan, for the treatment of patients with mild to moderate COVID-19 and to generate proof of concept for future trials.

NCT ID: NCT05163860 Completed - Health Behavior Clinical Trials

Family Relationships and Nutrition in TGGD Youth and Young Adults

Start date: December 27, 2021
Phase:
Study type: Observational

The purpose of this study is to assess how family relationships are related to health and nutrition behaviors among transgender and gender diverse youth and young adults.

NCT ID: NCT05163847 Completed - Influenza Vaccine Clinical Trials

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Start date: June 14, 2022
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, double-dummy, placebo-controlled Phase 1b study evaluating the safety and immunogenicity of the investigational Cam2020 M2SR H3N2 influenza vaccine delivered IN alone or concomitantly with inactivated influenza vaccine (IIV) delivered IM to a healthy adult population age 65 to 85 years at time of enrollment.

NCT ID: NCT05163730 Completed - COVID-19 Clinical Trials

Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This study is designed as a prospective, multicentric, clinical study to investigate the performance of the Panbio™ COVID-19/ Flu A&B Rapid Panel for the qualitative detection of COVID-19 antigen, Influenza A antigen (H1N1 and H3N2), and Influenza B antigen in human nasal swabs. This study is part of the performance evaluation to support the CE conformity assessment procedures.

NCT ID: NCT05163665 Completed - Clinical trials for Gastrointestinal Neoplasms

Cost-effective Analysis of Two Approximation Devices in Closure of Gastrointestinal Defects

Start date: August 23, 2022
Phase: N/A
Study type: Interventional

This is a prospective, randomized research trial that aims to evaluate the clinical results of two different approximation methods to close the tissue defect caused by removing gastrointestinal polyps.

NCT ID: NCT05163548 Completed - Clinical trials for Percutaneous Large Hole Vascular Closure

PerQseal®+ Early Feasibility Study

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

The objective of this Early Feasibility Study (EFS) is to evaluate the initial safety and preliminary effectiveness of the PerQseal®+ VCD in a small number of subjects when used to achieve hemostasis of common femoral arteriotomies created by 14 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing Percutaneous Transcatheter procedures.